🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

1/ We’re excited to announce our official launch and the closing of a $6.5M seed round to advance our pipeline of targeted therapies for solid tumors. Learn more 👉 businesswire.com/news/home/2024…

Thrilled to share that TwoStepTx has officially launched! With the closing of our seed round, we’ll be advancing our pipeline of targeted therapies for solid tumors. Many thanks to our incredible co-founders and investors for their support. Carolyn Bertozzi CochranLab

My dad died from colon cancer in 2020, NFX bio principal Gita Bassman Reinitz lots two parents to cancer, so many people we know are effected by this horrible disease.. businesswire.com/news/home/2024…

We are thrilled to announce our latest investment in TwoStepTx! Read more about why we invested 👇 2048.vc/blog/our-inves… 💡 Enabling targeted delivery to virtually any solid tumor using a unique and modular polyspecific integrin-binding peptide. 👩‍💻 The Founder:

congrats Caitlyn Miller and TwoStepTx on the launch! endpts.com/new-cancer-bio…

Our co-founder and CEO Caitlyn Miller spoke with Kyle LaHucik about our work developing a novel tumor-targeting platform for solid tumors - and how this approach opens up new possibilities for cancer treatment. Read more in Endpoints News News👇 endpts.com/new-cancer-bio…